Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rodocanachi Capital Inc. is a capital pool company listed on the TSX Venture Exchange. It has entered into a letter of intent to acquire Axcelon Biopolymers Corp., indicating a future focus in the biotech sector. Currently, there is no disclosed pipeline, clinical stages, or active R&D/clinical operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rodocanachi Capital Inc..